Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Alteon Inc. (AMEX:ALT)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug 14Earnings Announcement
July 25Price hit new 52-week low ($2.25)
Location
170 Williams Drive
Ramsey, NJ 07446
Phone: (201) 934-5000
Fax: (201) 934-8880
Email: spietropaolo@alteonpharma.com
Employees (last reported count): 26
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 15%
·Institutional: 16% (18% of float)
(27 institutions)
·Net Inst. Selling: 88.0K shares (+2.13%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Alteon Inc. is a product-based biopharmaceutical company engaged in the discovery and development of oral drugs for the treatment of diseases of aging and diabetes. The Company's product candidates represent novel approaches to some of the largest pharmaceutical markets, such as cardiovascular and kidney diseases. Two of the Company's compounds are in clinical development; several others are undergoing pre-clinical testing. These pharmaceutical candidates were developed as a result of the Company's understanding of the Advanced Glycosylation End-product (A.G.E.) pathway, a fundamental pathological process and inevitable consequence of aging that may result in many medical disorders.
More from Market Guide: Expanded Business Description

Financial Summary
Alteon Inc. is engaged in the discovery and development of new pharmaceutical products for the treatment of cardiovascular and renal diseases and other disorders of diabetes and aging. For the six months ended 6/30/01, revenues fell 18% to $253 thousand. Net loss applicable to Common rose 25% to $7.9 million. Revenues suffered from a decrease in cash, cash equivalents and short term investment balances. Higher loss also reflects increased personnel and R and D costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Kenneth Moch, 46
Chairman, Pres, CEO
$410K$6.6K
Robert DeGroof, Ph.D., 56
Sr. VP, Scientific Affairs
189K--  
Elizabeth O' Dell, 40
VP of Fin. and Admin., Sec., Treasurer
145K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:ALTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 25-July-2001
$2.25 
Recent Price$3.00 
52-Week High
on 14-Nov-2000
$8.313
Beta0.26 
Daily Volume (3-month avg)48.7K
Daily Volume (10-day avg)45.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change0.0%
52-Week Change
relative to S&P500
+34.2%
Share-Related Items
Market Capitalization$81.5M
Shares Outstanding27.2M
Float23.1M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.25 
Earnings (ttm)-$0.66 
Earnings (mrq)-$0.14 
Sales (ttm)$0.02 
Cash (mrq)$0.25 
Valuation Ratios
Price/Book (mrq)11.93 
Price/EarningsN/A 
Price/Sales (ttm)125.40 
Income Statements
Sales (ttm)$514.0K
EBITDA (ttm)-$11.1M
Income available to common (ttm)-$14.1M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-104.55%
Return on Equity (ttm)-163.28%
Financial Strength
Current Ratio (mrq)3.10 
Debt/Equity (mrq)0 
Total Cash (mrq)$5.65M
Short Interest
As of 8-Aug-2001
Shares Short255.0K
Percent of Float1.1%
Shares Short
(Prior Month)
0 
Short Ratio3.59 
Daily Volume71.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.